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The interest in circular RNAs has resurfaced in the past few years. What was considered
as “junk” for nearly two decades is now one of the most interesting molecules. Circular
RNAs are non-coding RNAs that are formed by back-splicing events and have covalently
closed loops with no poly-adenylated tails. The regulation of circular RNAs is distinctive
and they are selectively abundant in different types of tissues. Based on the current
knowledge of circular RNAs, these molecules have the potential to be the “next big thing”
especially as biomarkers for different diseases. This mini-review attempts to concisely
look at the biology of circular RNAs, the putative functional activities, the prevalence
of circular RNAs, and the possible role of circular RNA as biomarkers for diagnosis or
measuring drug response.
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INTRODUCTION
The transcriptome holds a wide array of information to actively regulate the cellular system. This
information comes in various forms such as mRNAs, microRNAs, long non-coding RNAs, and
piwi-interacting RNAs (Palazzo and Lee, 2015). There is a wide gap of information that we have yet
to retrieve from non-coding RNAs, but based on our current understanding, they are reported
to be involved in various processes such as gene expression, transcription, protein expression,
and scaffolding (Palazzo and Lee, 2015). One group of recently rediscovered non-coding RNAs
includes circular RNAs. Circular RNAs were once thought to be a tangential splicing event and were
regarded as an error (Chen et al., 2016). There are already several known circular RNAs derived
from viroids or other viruses (Rezaian, 1999). However, only recently the interest in circular RNAs
in humans has increased (Hentze and Preiss, 2013; Li et al., 2015a; Chen et al., 2016). Advances
in molecular techniques such as next generation sequencing and bioinformatics analysis have
provided key insights into the features of circular RNAs such as abundance, stability, conservation,
and tissue-specific expression. In this mini-review, we will attempt to illuminate the potential use
of circular RNAs as biomarkers.
In the non-coding RNA population, there are multiple species of RNA; therefore, there must be
a robust way to specifically detect circular RNAs. More importantly, the experimental design and
the bioinformatics analysis platform used should be validated and optimized. To detect circular
RNAs, there are several major pipelines that have been developed and validated, which are find_circ,
CIRI (Gao et al., 2015), MapSplice (Burd et al., 2010; Jeck et al., 2013), CIRCexplorer (Zhang
et al., 2014), circRNA_finder, and deepBase (Zheng L.-L. et al., 2016). There are also multiple
repositories for circular RNAs available such as circBase (Glažar et al., 2014), CircNet (Liu et al.,
2016b), circInteractome (Dudekula et al., 2016), and circ2traits (Ghosal et al., 2013). Circular RNAs
are characterized by a covalently continuous loop from the 5′ to 3′ ends (Lasda and Parker, 2014).
There are different types of circular RNAs such as exonic circular RNA, intronic circular RNA, and
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intergenic circular RNA (Lasda and Parker, 2014). The most
common type of circular RNA is the exonic circular RNA and is
always referred to as circRNA (Valdmanis and Kay, 2013; Lasda
and Parker, 2014). Circular RNAs are formed by a “back-splicing”
process which is an event mediated by a spliceosome that splices
a downstream 5′ splice site (splice donor) and joins it to an
upstream 3′ splice site (splice acceptor; Lasda and Parker, 2014;
Wilusz, 2015). Circular RNAs have been recently discovered and
have not been fully characterized yet. The diversity of circular
RNAs is wide; circular RNAs can be derived from numerous
genes and can have different levels of expression. Moreover,
circular RNAs can also have different sizes ranging from 100
nucleotides to 4 kb (Lasda and Parker, 2014; Ebbesen et al., 2016).
Additionally, circular RNAs may contain different numbers of
exons with different sized introns flanking the back-splice site
(Lasda and Parker, 2014; Ebbesen et al., 2016). It is postulated
that circular RNAs are conserved between human and the mouse
(Jeck et al., 2013). For instance, Jeck et al. found that there are
69 mice circular RNAs that have high homology to its respective
human circular RNAs (Jeck et al., 2013). However, there is
evidence that the percentage of the conserved region may not be
as high as previously thought (Guo et al., 2014). Furthermore,
the ratio between the circular RNA and the corresponding linear
RNA varies between different cell types and conditions. Some
studies report that the presence of circular RNAs is less than
10% of the linear RNA, however, other studies report that certain
circular RNAs aremore enriched than the linear RNAs depending
on different circumstances (Lasda and Parker, 2014). Thus, there
is a wide variation of circular RNAs but more research should
be done to discover if the variations are biologically relevant to
develop circular RNAs into biomarkers.
PUTATIVE FUNCTIONS OF CIRCULAR
RNAS
Infectious circular RNAs are known since long to be present
in multiple living organisms, including plants and animals.
In plants, infectious circular RNAs endowed of autonomous
replication (viroids) or depending on a helper virus (satellites)
have been reported (Rao and Kalantidis, 2015). In humans,
hepatitis delta virus, a well characterized infectious circular
RNA sharing structural properties with viroids (Flores et al.,
2016), is found in patients co-infected with hepatitis B virus.
However, other non-infectious endogenous circular RNAs have
been reported in animals and their role(s) remains sometimes
inconclusive (Wang et al., 2014). Some circular RNAs are
reported to be regulators of transcription in cis (Lasda and
Parker, 2014), while others are proposed to function as micro
RNA (miRNA) sponges (Chen et al., 2016). To date, there
are several circular RNAs that were reported to interact with
miRNAs (Burd et al., 2010; Hansen et al., 2013a,b; Jeck and
Sharpless, 2014). MiRNAs are known to have specific binding
sites for “sponges” such as mRNAs or in this case, circular
RNAs. If changes occur in the binding regions of these “sites,”
a downstream dysregulation of the entire network will bound to
occur and will lead to major events such as cancer progression,
neurological diseases, and cardiovascular diseases. One of the
most reported and extensively studied circular RNA is the ciRS-7
(Hansen et al., 2013a,b; Liu et al., 2014). Bioinformatics analysis
revealed that there are approximately seventy miR-7 binding sites
present on ciRS-7 (Hansen et al., 2013b; Jeck and Sharpless,
2014). A study by Memczak et al. using zebrafish proved that
there is an interaction between miR-7 and ciRS-7. The findings
demonstrated that ciRS-7 managed to reduce the level of miR-
7 activity by providing binding sites for miR-7 (“sponging”;
Hansen et al., 2013b; Memczak et al., 2013). Additionally, ciRS-7
has also been implicated in neurological diseases such as prion
disease and neuropathy (Satoh et al., 2009; Liu et al., 2014).
In Alzheimer’s disease (AD) and Parkinson’s disease (PD) for
example, ciRS-7 was found to be inactivated which in turns,
increased the level of miR-7 and eventually down regulated AD-
and PD- related targets (Lukiw, 2013; Memczak et al., 2013).
Another well-known circular RNA is the SRY circular RNA
that is expressed in the testis of mouse (Capel et al., 1993). This
circular RNA is known to be a sponge for miR-138 (Capel et al.,
1993; Ebert et al., 2007; Hansen et al., 2013a). Recently, another
circular RNA has been identified, circHIPK3, that was reported
to contribute to cancer progression. This particular circular RNA
can be derived from the exon of the HIPK3 gene and was found to
be abundant in cancer cells. Zheng et al. silenced the circHIPK3
circular RNA and found that it affected the growth of cancer cells.
Moreover, Zheng et al. also discovered multiple miRNA binding
sites on circHIPK3, and found that miR-124 exhibited the most
prominent binding effect (Zheng Q. et al., 2016). Additionally,
another circular RNA, circ-Foxo3, was found to be involved in
cell cycle progression and is highly expressed in non-cancer cells
(Du et al., 2016). It is suggested that circ-Foxo3 forms a ternary
complex with p21 andCDK2 to regulate the cell cycle process (Du
et al., 2016). It has also been reported that another circular RNA,
cZNF292, is regulated by hypoxia and displays pro-angiogenic
activities in endothelial cells (Boeckel et al., 2015). Nevertheless,
it is also suggested that cZNF292 does not act as amiRNA sponge,
thus providing insight that different circular RNAs have different
features and contributes to the regulatory network distinctively
from one another (Boeckel et al., 2015).
It has been proposed that circular RNAs might be involved in
protein expression since it has been shown that circular RNAs
have IRES (Hentze and Preiss, 2013; Jeck and Sharpless, 2014).
However, Guo et al. rebutted this concept because they did not
find any evidence that could explain whether circular RNAs
could be translated into proteins (Guo et al., 2014; Jeck and
Sharpless, 2014). Therefore, the validity of this theory remains
obscure and more research should be conducted to confirm this
notion. Additionally, the theory of circular RNAs interacting with
RNA-binding proteins remains plausible as circular RNAs have
been shown to bind to argonaute proteins and pol II (Hentze
and Preiss, 2013; Jeck and Sharpless, 2014). Recently, it has
been shown by Conn et al. (2015) that the RNA-binding protein
Quaking regulates the biogenesis of several circular RNAs in
response to epithelial-mesencyhmal transition (EMT) process
(Conn et al., 2015). Conn et al. findings suggest that a wide
number of circular RNAs are involved in EMT-related functions
such as invasion, migration, and adhesion (Conn et al., 2015).
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RELEVANCE OF CIRCULAR RNAS AS
BIOMARKERS
Biomarkers are defined as biological entities that can be found
in blood, bodily fluids, or tissues that can be a sign of a normal
or abnormal process, or of a condition or disease (Henry and
Hayes, 2012). The use of biomarkers has emerged as a means
of early detection and diagnosing different diseases as well as
measuring responses to certain treatments (Mayeux, 2004; Henry
and Hayes, 2012). There are several features of a biomarker that
renders it suitable for the use at the clinical setting. These features
include stability, sensitivity and specificity (Mayeux, 2004; Henry
and Hayes, 2012; Drucker and Krapfenbauer, 2013).
Circular RNAs Expressions are Cell
Specific
The existence of circular RNAs has been discovered in multiple
types of cancer (Qu et al., 2015b). For example, based on the
circBase repository, the presence of circular RNAs in different
types of cancer cell lines such as HeLa, MCF-7, A549, HepG2,
and K562 has been established (Salzman et al., 2013). It is shown
that circular RNAs are expressed specifically between cell types
and account for 1% of the total RNA population (Salzman et al.,
2013). Moreover, Salzman et al. has shown that different circular
RNA isoforms of the same gene are expressed differently in
different types of cell lines (Salzman et al., 2013). This suggests
that circular RNAs are expressed specifically and distinctively
from one another under certain conditions.
Circular RNAs are Selectively Abundant
It is important to note that the global abundance of circular
RNAs has been reported to be higher in low-proliferating cells
than high-proliferating cells (Bachmayr-Heyda et al., 2015). For
instance, the population of circular RNAs is highly abundant in
the brain as compared to other organs such as the liver (Memczak
et al., 2015; Rybak-Wolf et al., 2015). This notion was further
supported by a research conducted by Venø et al. that found high
spatio-temporal regulation of circular RNAs in the development
of the porcine embryonic brain (Venø et al., 2015). The theory
proposed by Bachmayr-Heyda et al. is that as cells proliferate,
the number of circular RNAs from the parent cell has to be
divided between the daughter cells, thus reducing the number of
circular RNAs in high-proliferating cells (Bachmayr-Heyda et al.,
2015). Theoretically, in the case of cancer, since cancer cells have
a high proliferation rate, the level of the total circular RNAs in
the cancerous tissues is lower than the corresponding normal
tissue (Bachmayr-Heyda et al., 2015). To prove this theory, a
study on colon cancer tissues revealed that the number of circular
RNAs was lower than the adjacent non-tumor tissue (Bachmayr-
Heyda et al., 2015). Interestingly, it has also been pointed out
that there is a large amount of circular RNAs circulating in the
blood (Memczak et al., 2015). Memczak et al. showed that the
population of circular RNAs in the blood is more prevalent than
in other organs/tissues, excluding the brain (Memczak et al.,
2015). Therefore, based on the study conducted by Bachmayr-
Heyda et al. and Memczak et al. the proposed level of abundance
of circular RNAs decreases in the following order; Brain: Blood
:Normal organs/tissue:Cancerous organs/tissue:Cell lines.
This suggests that the abundance of circular RNAs differ in
varying conditions, and thus, this piece of information can be
used to implement circular RNAs as biomarkers.
Circulating Circular RNAs
Since there are interests in using circulating entities in the
blood as biomarkers, the presence of circulating circular RNAs
was tested. Previously, Memczak et al. has established the
presence of circular RNAs in the blood. Subsequently, Li et al.
found that there were circular RNAs detected in extracellular
vesicles e.g., exosomes from serum samples (Li et al., 2015b).
Exosomes are a class of lipid bilayer extracellular vesicles, sized
from 40 to 150 nm that are released by cells (Raposo and
Stoorvogel, 2013; Zhang et al., 2015). Exosomes are considered
the “garbage bags” of the cellular system that contain unwanted
proteins, DNA and RNA (Properzi et al., 2013; Raposo and
Stoorvogel, 2013; Zhang et al., 2015). However, researchers
have discovered that these “unwanted” materials might hold
functional use after all. In fact, exosomes have been shown to
interact between cells by acting as messenger shuttles (Properzi
et al., 2013). Recently, it has been discovered that circular RNAs
are enriched in extracellular vesicles (Li et al., 2015c; Lasda and
Parker, 2016). A research conducted by Li et al. demonstrated
that circular RNAs are abundant in exosomes derived from
MHCC-LM3 xenograft models (Li et al., 2015c). It has been
shown that the relative abundance of circ-CDYL is positively
regulated in regard to the size of the tumor. This notion was
further translated and confirmed in the serum of 11 colorectal
cancer patients (Li et al., 2015c). Moreover, the expressions of
5 selected circular RNAs were also detected in the exosomes
secreted from the cell culture media of 3 different cell lines,
HeLa, 293T and U-2 OS cells (Lasda and Parker, 2016). The
presence of circular RNAs and the corresponding linear RNA
also varies between cell types and source (Lasda and Parker,
2016). It has been reported that the levels of the detected
circular RNAs were enriched in extracellular vesicles than the cell
lysates, as well as over its linear counterpart (Lasda and Parker,
2016).
As mentioned earlier, the level of circular RNAs in the
cancerous tissue is much lower than the normal tissue, however,
in the case of exosomes; the levels of selected circular RNAs
are higher in tumoral exosomes than normal exosomes (Li
et al., 2015c). It could be inferred that since cancer cells have
a higher proliferating rate capacity, the number of exosomes
or extracellular vesicles that sheds from that particular site is
higher than the normal cells. It is well known that in some
cancers, the level of exosomes is higher than in normal subjects,
therefore, theoretically, the level of circular RNAs should also be
higher (Baran et al., 2010; Giusti et al., 2013). Since extracellular
vesicles/exosomes are also potential biomarkers, the correlation
between the expression of exosomal proteins, miRNAs, and
circular RNAs could increase the sensitivity and specificity of
diagnosing multiple diseases as well as assessing responses to
drug treatments. Moreover, since there are possible interactions
between circular RNAs and RNA-binding proteins, there could
be an increase in the level of circulating circular RNAs. Figure 1
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FIGURE 1 | A schematic proposition on how circular RNAs function and are transported around the cellular system. There are many possibilities to the
function of circular RNAs such as sponging miRNA, binding to RNA binding proteins, being packaged into extracellular vesicles and exosomes and assisting in protein
translation.
summarizes the spatial role of circular RNAs given within a
cellular system.
Circular RNAs Vary in Different Diseases
Multiple studies have shown that circular RNAs are differentially
expressed between cancerous and non-cancerous samples
(Hansen et al., 2013b; Bachmayr-Heyda et al., 2015; Li et al.,
2015a,b; Wang et al., 2015a; Qin et al., 2016). It has been
reported that there is a dysregulation in the number of
circular RNAs between pancreatic ductal adenocarcinoma tissues
compared to healthy tissues (Qu et al., 2015a). For instance,
in gastric cancer tissues, the level of hsa_circ_00209 was
significantly down regulated than in the adjacent normal tissues
(Li et al., 2015b). This study also revealed the correlation
between the low level of hsa_circ_00209 and distal metastasis
(Li et al., 2015b). This information could be used to employ
circular RNAs as a biomarker for the detection of gastric
cancer. Also, the differential presence of circular RNAs in
laryngeal squamous cell cancer (LSCC) tissues has also been
reported (Xuan et al., 2016). The level of hsa_circRNA_100855
was higher in LSCC tissues, while hsa_circRNA_104912
TABLE 1 | Circular RNAs that were reported to be potential biomarkers to
detect specific diseases.
Disease Circular RNA References
Gastric cancer Hsa_circ_002059 Li et al., 2015b
Laryngeal squamous cell cancer Hsa_circ_100855 Xuan et al., 2016
Hsa_circ_104912 Xuan et al., 2016
Colorectal cancer circ-CDYL Li et al., 2015b
Hsa_circ_001988 Wang et al., 2015a
Hsa_circ_001569 Xie et al., 2016
Hepatocellular carcinoma (tissue) Hsa_circ_0001649 Qin et al., 2016
Hsa_circ_0005075 Shang et al., 2016
Chronic CD28-associated CD8(+)T
cell aging
circular RNA100783 Wang et al., 2015b
Pre-eclampsia circ_101222 Zhang et al., 2016
was lower in LSCC tissues than non-tumorigenic tissues
(Xuan et al., 2016).
Moreover, it has also been reported that there are varying
levels of circular RNAs in cutaneous squamous cell carcinoma
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(Sand et al., 2016a). A total of 322 circular RNAs were
differentially expressed between cutaneous squamous cell
carcinoma and non-lesional skin biopsies (Sand et al., 2016a).
Similarly, the same group also discovered 71 differentially
expressed circular RNAs in basal cell carcinoma (Sand et al.,
2016b). Additionally, in ovarian cancer, Ahmed et al. showed
that there was a significant difference in the level of circular
RNAs between primary ovarian tumor and metastasis ovarian
lesions (Ahmed et al., 2016). The number of circular RNAs
detected was much higher than the corresponding linear mRNA
in metastatic samples as compared to the primary ovarian
tumor samples (Ahmed et al., 2016). The results suggested that
circular RNAs could be used to detect and diagnose different
subtypes of cancer. Additionally, it was reported that the level of
circular RNAs differs between osteoarthritis cartilage and normal
cartilage, around 71 circular RNAs were found to be differentially
expressed (Liu et al., 2016a). Furthermore, in a pre-eclampsia
study, 12 differentially expressed circular RNAs were discovered
(Zhang et al., 2016). Table 1 lists the type of circular RNA that
has been suggested as potential biomarkers of specific diseases.
CONCLUSION
The use of circular RNA as biomarkers is a promising approach
due to several reasons; (1) Circular RNAs are stable as they
are not as susceptible to nucleases as linear RNA (Jeck and
Sharpless, 2014). Moreover, circular RNAs have longer half-
lives as compared to their linear counterparts (Enuka et al.,
2016). (2) Circular RNAs are relatively abundant, especially in
the blood (Jeck et al., 2013). The development and utilization
of blood-based biomarkers are increasing because the analysis
is fast, reliable, and cost-effective. Moreover, minimally-invasive
procedures are deemed to be more favorable. (3) The level of
circular RNAs is different between healthy and diseased subjects
which increases the sensitivity and specificity of the target. The
popularity of circular RNAs has steadily increased over the past
years, thus understanding the functional mechanism of circular
RNAs would be of great value. Hopefully in the future, the
elucidation of the role of circular RNAs will be established and
the use of circular RNAs will become routine in the clinical
practice.
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